Resumo
Diagnósticos diferenciais
comuns
- Doença de lesão mínima
- Glomeruloesclerose segmentar focal (GESF)
- Nefropatia membranosa
- Nefropatia diabética
- Amiloidose de cadeia leve (amiloidose do tipo AL) associada a mieloma múltiplo
- Nefropatia por imunoglobulina A (IgA)
Incomuns
- Glomerulonefrite membranoproliferativa (mesangiocapilar)
- Amiloidose
- Nefrite lúpica
- Doença de Fabry
- Síndrome de Alport
- Síndrome de unha-patela
- Hipertensão maligna
Colaboradores
Autores
Panduranga Rao, MD, DNB, MS
Richard D Swartz Collegiate Professor of Nephrology
Professor of Medicine
Department of Medicine
University of Michigan
Ann Arbor
MI
Declarações
PR declares that he has no competing interests.
Benjamin Wagner, MD
Assistant Professor of Medicine
Department of Medicine
University of Michigan
Ann Arbor
MI
Declarações
BW declares that he is a co-investigator on "An Open Label Phase 1b Study of Felzartamab in Lupus Nephritis", a study sponsored by HI-Bio.
Agradecimentos
Dr Panduranga Rao and Dr Benjamin Wagner would like to gratefully acknowledge Dr Ruth Pepper, Dr John Connolly, Dr David J.A. Goldsmith, Dr Oliver J. Ziff, and Dr Michael S. Gersch, previous contributors to this topic.
Declarações
RP, JC, DJAG, OJZ, and MSG declare that they have no competing interests.
Revisores
John Feehally, MBBS, FRCP
Professor of Renal Medicine
The John Walls Renal Unit
Leicester General Hospital
Leicester
UK
Disclosures
JF declares that he has no competing interests.
Judith H. Veis, MD, FASN
Associate Director
Nephrology
Washington Hospital Center
Washington
DC
Disclosures
JHV declares that she has no competing interests.
Catherine Clase, BA, MB, MSC, FRCPC
Associate Professor
Department of Medicine
McMaster University
Ontario
Canada
Disclosures
CC declares that she has no competing interests.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
References
Key articles
Nishi S, Ubara Y, Utsunomiya Y, et al. Evidence-based clinical practice guidelines for nephrotic syndrome 2014. Clin Exp Nephrol. 2016 Jun;20(3):342-70.Full text Abstract
Trautmann A, Boyer O, Hodson E, et al. IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol. 2023 Mar;38(3):877-919.Full text Abstract
Kidney Disease Improving Global Outcomes Glomerular Diseases Work Group. KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int. 2021 Oct;100(4S):1-276.Full text
Reference articles
A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
Guidelines
- IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
- KDIGO clinical practice guideline for the management of glomerular diseases
More Guidelines
Log in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer